Bio-Rad Laboratories

BIO.B · NYSE

$379.50+$15.35 (+4.22%)TodayMarket closed · Oct 27, 7:30 PM ET

No price history for this range.

BIO.B analyst rating

HoldConsensus of 5 analysts over the last 12 months. 20% rate it a buy.

Strong buy0
Buy1
Hold4
Underperform0
Sell0

12-month price target · 6 analysts

Average $373.49 (−1.6% downside)

Low: $341.78
Now: $379.50
High: $413.65

Upgrades and downgrades

The latest rating actions, newest first

BIO.B analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Aug 7, 2026	Maintains	Outperform	$370.00 → $390.00	59%
Citigroup	Aug 5, 2026	Maintains	Neutral	$300.00 → $330.00	44%
RBC Capital	Aug 5, 2026	Maintains	Outperform	$320.00 → $370.00	59%
Wells Fargo	Aug 5, 2026	Maintains	Equal-Weight	$310.00 → $330.00	100%
RBC Capital	May 15, 2026	Initiates	Outperform	$320.00	59%
Wells Fargo	May 1, 2026	Maintains	Equal-Weight	$320.00 → $290.00	66%
Citigroup	Apr 7, 2026	Downgrade	Buy → Neutral	$375.00 → $300.00	55%
Wells Fargo	Feb 16, 2026	Maintains	Equal-Weight	$340.00 → $320.00	66%
Citigroup	Oct 30, 2025	Maintains	Buy	$350.00 → $375.00	55%
Wells Fargo	Oct 30, 2025	Maintains	Equal-Weight	$265.00 → $340.00	66%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.